UnitedHealth Group Incorporated
UNH| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B |
| Cost of Revenue | $364.65B | $310.88B | $280.66B | $244.54B | $217.94B | $190.14B | $184.56B | $172.40B |
| Gross Profit | $82.92B | $89.40B | $90.96B | $79.62B | $69.65B | $67.00B | $57.60B | $53.85B |
| Gross Margin | 18.53% | 22.33% | 24.48% | 24.56% | 24.22% | 26.06% | 23.79% | 23.80% |
| Operating Expenses | $63.95B | $57.11B | $58.60B | $51.18B | $45.68B | $44.59B | $37.91B | $36.50B |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B |
| Operating Margin | 4.24% | 8.07% | 8.71% | 8.77% | 8.33% | 8.71% | 8.13% | 7.67% |
| Net Income | $14.23B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B |
| Net Margin | 3.18% | 3.60% | 6.02% | 6.21% | 6.01% | 5.99% | 5.71% | 5.30% |
| EPS (Basic) | $15.66 | $15.64 | $24.12 | $21.54 | $18.33 | $16.28 | $14.55 | $12.45 |
| EBITDA | N/A | $28.08B | $36.33B | $31.84B | $27.07B | $25.30B | $22.41B | $19.77B |
| Stock Option Compensation Expense | N/A | $1.02B | $1.06B | $925.00M | $800.00M | $679.00M | $697.00M | $638.00M |
| Price To Earnings Ratio | N/A | 32.62 | 21.83 | 24.61 | 27.39 | 21.54 | 20.20 | 20.02 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | $469.94B | $488.56B | $495.19B | $473.52B | $331.74B | $279.57B | $239.90B |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $100.09B | $92.66B | $88.76B | $77.77B | $71.76B | $65.49B | $57.62B | $51.70B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $100.09B | $92.66B | $88.76B | $77.77B | $71.76B | $65.49B | $57.62B | $51.70B |
| Total Liabilities & Stockholders Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B |
| Book Value Per Share | N/A | $110.43 | $106.59 | $92.45 | $81.10 | $74.57 | $65.36 | $58.39 |
| Tangible Book Value Per Share | N/A | $-29.51 | $-21.56 | $-22.92 | $-9.93 | $-12.32 | $-14.56 | $-12.47 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | 4.83% | 8.18% | 8.19% | 8.15% | 7.81% | 7.96% | 7.87% |
| Return on Equity | N/A | 15.55% | 25.22% | 25.87% | 24.09% | 23.52% | 24.02% | 23.19% |
| Return on Invested Capital | N/A | 12.32% | 14.29% | 13.96% | 13.85% | 13.13% | 13.44% | 13.34% |
| Quick Ratio | N/A | 0.83 | 0.79 | 0.77 | 0.79 | 0.74 | 0.69 | 0.73 |
| Current Ratio | N/A | 0.83 | 0.79 | 0.77 | 0.79 | 0.74 | 0.69 | 0.73 |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $14.23B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B |
| Depreciation | N/A | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $38.29B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B |
| Capital Expenditures | N/A | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Show 12 more stories
Insider Trading
View AllCompany
About the company
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.